These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38498313)

  • 21. Clinically based score predicting cryptogenic NORSE at the early stage of status epilepticus.
    Yanagida A; Kanazawa N; Kaneko J; Kaneko A; Iwase R; Suga H; Nonoda Y; Onozawa Y; Kitamura E; Nishiyama K; Iizuka T
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32727813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data.
    Nabbout R; Matricardi S; De Liso P; Dulac O; Oualha M
    Front Neurol; 2023; 14():1134827. PubMed ID: 37122314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: A systematic review and meta-analysis.
    Tharmaraja T; Ho JSY; Neligan A; Rajakulendran S
    Epilepsia; 2023 May; 64(5):1113-1124. PubMed ID: 36727541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New-onset refractory status epilepticus (NORSE) in paediatric patients: causes, characteristics and outcomes.
    Tainski de Azevedo AL; Tedesco Tonial C; Andrades GRH; Abud Drumond Costa C; Crestani F; Rodrigues Lessa A; Bruno F; Carvalho P; Eckert G; Piva J; Celiny Ramos Garcia P
    BMJ Neurol Open; 2022; 4(2):e000314. PubMed ID: 36530417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries.
    Kazazian K; Kellogg M; Wong N; Eschbach K; Moeller RF; Gaspard N; Hirsch LJ; Hocker S; Gofton T
    Epilepsy Curr; 2021 Mar; ():1535759721998329. PubMed ID: 33663265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Cell Transcriptomic Analyses of Brain Parenchyma in Patients With New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Zhang L; Huttner AJ; Plu I; Mathon B; Bielle F; Navarro V; Hirsch LJ; Hafler DA
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200259. PubMed ID: 38810181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New-onset refractory status epilepticus: A retrospective cohort study.
    Gugger JJ; Husari K; Probasco JC; Cervenka MC
    Seizure; 2020 Jan; 74():41-48. PubMed ID: 31830676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The timelines of MRI findings related to outcomes in adult patients with new-onset refractory status epilepticus.
    Kim HJ; Lee SA; Kim HW; Kim SJ; Jeon SB; Koo YS
    Epilepsia; 2020 Aug; 61(8):1735-1748. PubMed ID: 32715470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology of new-onset refractory status epilepticus (NORSE) in adults.
    Suchdev K; Kupsky WJ; Mittal S; Shah AK
    Seizure; 2021 Dec; 93():95-101. PubMed ID: 34740145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responsive neurostimulation as a therapy for epilepsy following new-onset refractory status epilepticus: Case series and review of the literature.
    Oliger A; Nerison C; Tan H; Raslan A; Ernst L; Datta P; Kellogg M
    Clin Neurophysiol; 2024 Jun; 162():151-158. PubMed ID: 38640819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early clinical features of new-onset refractory status epilepticus (NORSE) in adults.
    Haanpää A; Laakso SM; Kinnunen A; Kämppi L; Forss N
    BMC Neurol; 2022 Dec; 22(1):495. PubMed ID: 36539824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NORSE seasonality may vary geographically in adults.
    Bolle AE; Gaist T; Kuljis AME; Blaabjerg M; Beier CP
    Epilepsia Open; 2024 Jun; 9(3):1088-1095. PubMed ID: 38635008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
    Carson R; Stredny CM
    Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New-Onset Refractory Status Epilepticus in Children: Etiologies, Treatments, and Outcomes.
    Husari KS; Labiner K; Huang R; Said RR
    Pediatr Crit Care Med; 2020 Jan; 21(1):59-66. PubMed ID: 31568262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptogenic new-onset refractory status epilepticus (NORSE) following blood transfusion in a patient with severe anemia.
    Wu CK; Culbertson CJ; Von Stein EL; Walia S; Krishnamohan P; Threlkeld ZD
    Epileptic Disord; 2021 Apr; 23(2):403-406. PubMed ID: 33881399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome in new onset refractory status epilepticus: a retrospective study.
    Stretti F; Bögli SY; Casagrande F; Eisele A; Galovic M; Keller E; Brandi G
    Crit Care; 2024 Mar; 28(1):72. PubMed ID: 38475798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity.
    Wilder-Smith EP; Lim EC; Teoh HL; Sharma VK; Tan JJ; Chan BP; Ong BK
    Ann Acad Med Singap; 2005 Aug; 34(7):417-20. PubMed ID: 16123813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines in New-Onset Refractory Status Epilepticus Predict Outcomes.
    Hanin A; Cespedes J; Dorgham K; Pulluru Y; Gopaul M; Gorochov G; Hafler DA; Navarro V; Gaspard N; Hirsch LJ
    Ann Neurol; 2023 Jul; 94(1):75-90. PubMed ID: 36871188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
    Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
    Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.
    Gall CR; Jumma O; Mohanraj R
    Seizure; 2013 Apr; 22(3):217-20. PubMed ID: 23333762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.